Reimbursed Care Access in Tokelau

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no public evidence of a Tokelau-specific medical prescribing, reimbursement, or supervised therapeutic program for psilocybin; Tokelau law is developed locally and New Zealand statutes are not automatically in force in Tokelau unless expressly extended. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no public record of MDMA-based therapy access, reimbursement, or authorized medical programs operating in Tokelau. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical reimbursement framework or documented local program in Tokelau. There is no publicly available evidence that esketamine (or a reimbursed esketamine service) is authorized or delivered within Tokelau; any specialist services would typically be delivered off‑island under referral arrangements. #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical reimbursement framework for psychedelic/psychotherapeutic uses in Tokelau. While ketamine is an internationally used anaesthetic agent in many jurisdictions, there is no publicly available Tokelau policy or reimbursement scheme describing medical or off‑label psychiatric ketamine services on the atolls; health services in Tokelau are extremely limited and specialist care is generally referred off‑island. #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. No Tokelau-specific medical access, licensing or reimbursement pathways for DMT have been identified in public sources. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. No evidence of authorized clinical programs, reimbursement, or legal medical access for 5‑MeO‑DMT in Tokelau. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no public record of authorized ibogaine treatment clinics, licensing, or reimbursement in Tokelau. #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Traditional or sacramental uses of ayahuasca would not be documented as lawful medical/reimbursed treatments in Tokelau public law sources; no authorized clinical or reimbursement pathways are publicly recorded. #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. No Tokelau-specific licensing, therapeutic programs, or reimbursement arrangements for mescaline have been identified in public sources. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no public evidence that any 2C family compound has authorized medical, clinical‑trial, or reimbursed access in Tokelau. # #.